SIERRA ONCOLOGY
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Mar 2024)
What this means for you
This application is over — abandoned 04 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90848313
- Mark type
- Stylized text
- Filed
- 26 Jul 2021
- Published for opposition
- 06 Dec 2022
- Abandoned
- 04 Mar 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Biological and chemical preparations for the treatment of cancer; pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and disorders; pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue and organ implantation; pharmaceutical preparations for use in the prevention and treatment of dermatology, oncology, hematology and for gastroenterological disorders but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue and organ implantation
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines; medical research; pharmaceutical research and development services; medical research services in the field of cancer; research and development of biological and chemical preparations for the treatment of blood diseases, bone and bone marrow diseases, and cancer; research and development of pharmaceutical products, preparations and compounds for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development of pharmaceutical preparations for use in dermatology, oncology, hematology, and for gastroenterological disorders; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials regarding pharmaceutical preparations and drugs in the field of blood diseases, and cancers; DNA screening and analysis services for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Medical services; medical services for the treatment of cancer; medical analysis services for the diagnosis and treatment of patients and persons; medical analysis services for the diagnosis of cancer; providing cancer screening services; providing a website via a global computer network featuring information in the fields of health and health information regarding cancer, cancer treatment, recovery and survival; medical evaluation and diagnosis of cancer; medical analysis for cancer diagnosis and prognosis based on DNA and RNA screening; medical services for the diagnosis of conditions of the human body; providing a website via a global computer network featuring information regarding the medical diagnosis and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website via a global computer network featuring information regarding the medical diagnosis and treatment of dermatology, oncology, hematology, and for gastroenterological disorders; providing medical information, consultancy and advisory services; providing links to the websites of others featuring information about the diagnosis and treatment of cancer
Owner
- SIERRA ONCOLOGY LLC, WILMINGTON, DE, US
- Sierra Oncology, Inc., San Mateo, CA, US
- Sierra Oncology, Inc., San Mateo, CA, US
Prosecution history
- 04 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2023 — SOU EXTENSION 1 GRANTED
- 31 Jul 2023 — SOU EXTENSION 1 FILED
- 31 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Dec 2022 — PUBLISHED FOR OPPOSITION
- 16 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Oct 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED